Neu H.C. (1982) Clinical use of aminoglycosides. The Aminoglycosides: Microbiology, Clinical Use and Toxicology , A Whelton, HC Neu. Dekker, New York; 611-628.
Lietman P.S. (1985) Aminoglycosides and spectinomycin: aminocyclitols. Principles and Practice of Infectious Diseases , GL Mandell, RG Douglas, JE Bennett. Wiley, New York; 192-206.
Sande M.A., Mandell G.L. (1985) Antimicrobial agents. The aminoglycosides. The Pharmacological Basis of Therapeutics , A Goodman Gilman, LS Goodman, TW Rail, F Murad. Macmillan, New York; 1150-1169.
Price K. (1986) Aminoglycoside research 1975–1985. Prospects for development of improved agents. Antimicrob Agents Chemother 29:543-548.
Appel G.B., Neu H.C. (1978) Gentamicin in 1978. Ann Intern Med. 89:528-538.
Kahlmeter G., Dahlager J.I. (1984) Aminoglycoside toxicity—A review of clinical studies published between 1975 and 1982. J Antimicrob Chemother , suppl A; 13:9-22.
Mathews A., Bailie G.R. (1987) Clinical pharmacokinetics, toxicity and cost effectiveness analysis of aminoglycosides and aminoglycoside dosing services. J Clin Pharm Ther. 12:273-291.
Tulkens P.M. (1989) Nephrotoxicity of aminoglycoside antibiotics. Toxicol Lett 46:107-123.
Houghton D.C., Hartnett M.V., Campbell-Boswell M.V., Porter G., Bennett W. (1976) A light and electron microscopic analysis of gentamicin nephrotoxicity in rats. Am J Pathol. 82:589-612.
Houghton D.C., Plamp C.E., De Fehr J.M., Bennett W.M., Porter G., Gilbert D. (1978) Gentamicin and tobramycin nephrotoxicity. A morphologic and functional comparison in the rat. Am J Pathol. 93:137-152.
Fabre J., Rudhardt M., Blanchart P., Regamey C. (1979) Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int. 10:444-449.
Silverblatt F.J., Kuehn C. (1979) Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int. 15:335-345.
De Broe M.E., Giuliano R.A., Verpooten G.A. (1988) Insights into the renal handling of aminoglycosides: a guideline for prevention of nephrotoxicity. J Drug Dev , suppl. 3; 83-92.
De Broe M.E., Paulus G.J., Verpooten G.A., Roels F., Buyssens N., Wedeen R., Van Hoof F., Tulkens P.M. (1984) Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kidney Int. 25:643-652.
Giurgea-Marion L., Toubeau G., Laurent G., Heuson-Stiennon J.A., Tulkens P.M. (1986) Impairment of lysosome-pinocytic vesicle fusion in rat proximal tubules after treatment with gentamicin at low dose. Toxicol Appl Pharmacol. 86:271-285.
Tulkens P.M. (1986) Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives. Am J Med. , suppl 6B; 105-114.
Laurent G., Toubeau G., Heuson-Stiennon J.A., Tulkens P., Maldague P. (1988) Kidney tissue repair after nephrotoxic injury: biochemical and morphological characterization. CRC Crit Rev Toxicol. 19:147-183.
Toubeau G., Laurent G., Carlier M.B., Abid S., Maldague P., Heuson-Stiennon J.A., Tulkens P. (1985) Tissue repair in rat kidney cortex following short treatment with aminoglycosides at low doses: a comparative biochemical and morphometric study. Lab Invest. 54:385-393.
Gabe M. Techniques histologiques , Paris, Masson; 1968, 191-198.
Holgate C.S., Jackson P., Cowen P.N., Bird C.C. (1983) Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem 31:938-944.
Hacker G.W., Springall D.R., Van Noorden S., Bishop A.E., Grimelius L., Polak J.M. (1985) The immunogold-silver staining method: a powerful tool in histopathology. Virchow Arch (Pathol Anat) 406:449-461.
Nonclercq D., Toubeau G., Lambricht P., Heuson-Stiennon J.A., Laurent G. (1991) Redistribution of epidermal growth factor immuno-reactivity in renal tissue after nephrotoxin-induced tubular injury. Nephron 57:210-215.
Ward J.M., Hagiwara A., Anderson L.M., Lindsey K., Diwan B.A. (1988) The chronic hepatic or renal toxicity of di(2-ethylhexyl)phtalate, acetaminophen, sodium barbital, and phenobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical, and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion. Toxicol AppI Pharmacol. 96:494-506.
Toubeau G., Nonclercq D., Zanen J., Lambricht P., Tulkens P.M., Heuson-Stiennon J.A., Laurent G. (1991) Distribution of epidermal growth factor in the kidneys of rats exposed to ascending doses of amikacin. Kidney Int. 40:691-699.
Nonclercq D., Toubeau G., Laurent G., Tulkens P.M., Heuson-Stiennon J.A. (1989) Tissue injury and repair in the rat kidney after exposure to cisplatin and carboplatin. Exptl Mol Pathol. 51:123-140.
Schaudies R.P., Savage C.R. (1986) Isolation of rat epidermal growth factor (r-EGF): chemical, biological and immunological comparisons with mouse and human EGF. Comp Biochem Physiol. 84B:497-505.
Sternberger L.A., Hardy P.H., Cuculis J., Meyer H.G. (1970) The unlabeled antibody enzyme method of immunocytochemistry. Preparation and properties of soluble antigen-antibody complex (Horseradish peroxidase antihorseradish peroxidase) and its use in the identification of spirochetes. J Histochem Cytochem 18:315-333.
Feldman S., Wang M.Y., Kaloyanides G.J. (1982) Aminoglycosides induce a phospholipidosis in the renal cortex of the rat: an early manifestation of nephrotoxicity. J Pharmacol Exp Ther. 220:514-520.
Laurent G., Carlier M.B., Rollmann B., Van Hoof F., Tulkens P. (1982) Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol. 31:3861-3870.
Tulkens P.M., De Broe M.E., Maldague P., Heuson-Stiennon J.A. (1984) Lysosomal alterations in aminoglycoside-induced acute renal failure. Acute Renal Failure—Correlations between Morphology and Function , K Solez, A Whelton. Dekker, New York; 299-327.
LÜLlman H., Vollmer B. (1982) An interaction of aminoglycoside antibiotics with Ca binding to lipid monolayers and to biomem-branes. Biochem Pharmacol. 31:3769-3773.
Hostetler K.Y., Hall L.B. (1982) Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanisms of aminoglycoside toxicity. Proc Natl Acad Sci USA 79:1663-1667.
Carlier M.B., Laurent G., Claes P.J., Vanderhaeghe H.J., Tulkens P.M. (1983) Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies. Antimicrob Agents Chemother 23:440-449.
Brasseur R., Laurent G., Ruysschaert J.M., Tulkens P. (1984) Interactions of aminoglycoside antibiotics with negatively charged lipid layers. Biochem Pharmacol. 33:629-637.
Mingeot-Leclercq M.P., Laurent G., Tulkens P.M. (1988) Biochemical mechanism of aminoglycoside-induced inhibition of phosphatidylcholine hydrolysis by lysosomal phospholipases. Biochem Pharmucol 37:591-599.
Ramsammy L.S., Josepovitz C., Lane B., Kaloyanides G.J. (1989) Effect of gentamicin on phospholipid metabolism in cultured rabbit proximal tubular cells. Am J Physiol. 256:C204-C213.
Aubert-Tulkens G., Van Hoof F., Tulkens P. (1979) Gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts. Lab Invest. 40:481-491.
Kishore B.K., Lambricht P., Laurent G., Maldague P., Wagner R., Tulkens P.M. (1990) Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids. J Pharmacol Exp Ther. 255:875-885.
Tulkens P.M., Laurent G. (1984) Mechanisms of aminoglycoside-induced nephrotoxicity: a review of experimental studies in animals with gentamicin and four other aminoglycosides (amikacin, tobramycin. netilmicin and dibekacin) at low doses. Chemioterapia III , supp 5; 60-7l.
Ramsammy L., Josepovitz C., Lane B., Kaloyanides G.J. (1990) Polyaspartic acid inhibits gentamicin-induced perturbations of phospholipid metabolism. Am J Physiol. 258:C1141-C1149.
Beauchamp D., Laurent G., Maldague P., Abid S., Kishore B.K., Tulkens P.M. (1990) Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid. J Pharmacol Exp Ther. 255:858-866.
Kishore B.K., Kallay Z., Lambricht Laurent P.G., Tulkens P.M. (1990) Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro. J Pharmacol Exp Ther. 255:867-874.
Cuppage F.E., Tate A. (1967) Repair of the nephron following injury with mercuric chloride. Am J Pathol. 51:405-429.
Laurent G., Maldague P., Carlier M.B., Tulkens P.M. (1983) Increased DNA synthesis in vivo after administration of low doses of gentamicin to rats. Antimicrob Agents Chemother 24:586-593.
Short B.G., Burnett V.L., Cox M.G., Bus J.S., Swenberg J.A. (1987) Site-specific renal cytotoxicity and cell proliferation in male rats exposed to petroleum hydrocarbons. Lab Invest. 57:564-577.
Laurent G., Yernaux V., Nonclercq D., Toubeau G., Maldague P., Tulkens P.M., Heuson-Stiennon J.A. (1988) Tissue injury and proliferative response induced in rat kidney by cis-diamminedichloro-platinum (II). Virchows Arch B—Cell Pathol. 55:129-145.
Matsumoto K., Lambricht P., Kishore B.K., Ibrahim S., Rollmann B., Laurent G., Tulkens P.M. (1988) Vitro and in vivo evaluation of the early renal alterations induced by HAPA-gentamicin B (Isepa-micin: IP)., Presented at the 28th Intersci Conf Antimicrob Agents Chemother. Los Angeles; .
Lambricht P., Kishore B.K., Ibrahim S., Wagner R., Maldague P., Laurent G., Tulkens P.M. (1989) Evaluation of micronomicin nephrotoxic potential in rats at low and high doses., Presented at the 29th Intersci Conf Antimicrob Agents Chemother. Houston; .
Nonclercq D., Toubeau G., Laurent G., Maldague P., Tulkens P.M., Heuson-Stiennon J.A. (1988) Light and electron microscopic characterization of the proliferative response induced by tobramycin in rat kidney cortex. Exptl Mol Pathol. 48:335-352.
Porter G.A., Laurent G., Maldague P., Tulkens P. (1984) Gentamicin-induced stimulation of DNA synthesis in rat kidney. Comparison between in vivo and in vitro models. Toxicol Lett 23:205-213.
Mendley S.R., Toback F.G. (1988) Autocrine and paracrine regulation of kidney epithelial cell growth. Annual Rev Physiol. 51:33-50.
Scott J., Patterson S., Rail L., Bell G.I., Crawford R., Penshow J., Niall H., Coghlan J. (1985) The structure and biosynthesis of epidermal growth factor precursor. J Cell Sci. , suppl 3; 19-28.
Norman J., Badie-Dezfooly B., Nord E.P., Kurtz I., Schlosser J., Chaudhari A., Fine L.G. (1987) EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol. 253:F299-F309.
Goodyer P.R., Kachra Z., Bell C., Rozen R. (1988) Renal tubular cells are potential targets for epidermal growth factor. Am J Physiol. 255:F119I-F1196.
Humes H.D., Beals T.F., Cieslinski D.A., Sanchez I.O., Page T.P. (1991) Effects of transforming growth factor-β transforming growth factor å, and other growth factors on renal proximal tubule cells. Lab Invest. 64:538-545.
Humes H.D., Cieslinski D.A., Coimbra T.M., Messana J.M., Galvao C. (1989) Epidermal growth factor enhances renal tubule cell regeneration and accelerates the recovery of renal function in post-ischemic acute renal failure. J Clin Invest. 84:1757-1761.
Norman J., Tsau Y.K., Bacay A., Fine L.G. (1990) Epidermal growth factor accelerates functional recovery from ischemic acute tubular necrosis in the rat. Role of the epidermal growth factor receptor. Clin Sci (Lond) 78:445-450.
Salido E.C., Yen P.H., Shapiro U., Fisher D.A., Barajas L. (1989) Situ hybridization of prepro-epidermal growth factor messenger RNA in the mouse kidney. Am J Physiol. 256:F632-F638.
Safirstein R., Zelent A.Z., Price P.M. (1989) Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARE. Kidney Int. 36:810-815.
Safirstein R., Price P.M., Saggi S.J., Harris R.C. (1990) Changes in gene expression after temporary renal ischemia. Kidney Int. 37:1515-1521.
Salido E.C., Fisher D.A., Barajas L. (1986) Immunoelectron microscopy of epidermal growth factor in mouse kidney. J Ultrastruct Mol Struct Res. 96:105-113.
Breyer J.A., Cohen S. (1990) The epidermal growth factor precursor isolated from murine kidney membranes. J Biol Chem. 265:16564-16570.
Seiken G.L., Schaudies R.P. (1991) Tissue levels of EGF in acute renal failure in rats. FASEB J. , five; A909.
